A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2223303
Method for the treatment of multiple sclerosis and other T cell mediated autoimmune disorders is described. The method involves administering to a subject a therapeutically effective amount of an antagonist of a receptor on a surface of a T cell which mediates contact dependent helper effector functions, for example, an anti-gp39 antibody.
L'invention concerne un procédé de traitement de la sclérose en plaques et d'autres maladies auto-immunes induites par les lymphocytes T. Ce procédé consiste à administrer à un sujet une dose thérapeutique efficace d'un antagoniste d'un récepteur sur la surface des lymphocytes T qui assure la médiation de la fonction d'effecteur auxiliaire activé par contact, par exemple d'un anticorps anti-récepteur gp39.
Chaassen Eric
Noelle Randolph J.
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk On
Smart & Biggar
Trustees Of Dartmouth College
LandOfFree
Treatment of t cell mediated autoimmune disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of t cell mediated autoimmune disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of t cell mediated autoimmune disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2089225